68
Views
16
CrossRef citations to date
0
Altmetric
Article

Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time

, , , &
Pages 112-117 | Received 31 Oct 2002, Accepted 10 Mar 2003, Published online: 10 Jul 2009

References

  • Munsat TL. Development of measurement techniques. Neurology 1996; 47(Suppl 2): S83–S85.
  • Brooks BR. Clinical evaluation of ALS drugs. Neurology 1997; 48(Suppl 4): S23–S27.
  • Jenkinson C, Swash M, Fitzpatrick R. The European Amyotrophic Lateral Sclerosis Health Profile Study. ALS-HPS Steering Group. J Neurol Sci 1998; 160(Suppl 1): S122–S126.
  • Young CA, Tedman BM, Williams IR. Disease progression and perceptions of health in patients with motor neurone disease. J Neurol Sci 1995; 129(suppl): 50–53.
  • Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 1997; 152(Suppl 1): S75–S79.
  • Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30(6): 473–483.
  • Simmons Z, Bremer BA, Robbins RA et al. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000; 55(3): 388–392.
  • Robbins RA, Simmons Z, Bremer BA et al. Quality of life in ALS is maintained as physical function declines. Neurology 2001; 56(4): 442–444.
  • Clarke S, Hickey A, O’Boyle C, Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 2001; 10(2): 149–158.
  • Jenkinson C, Fitzpatrick R, Swash M, Peto V. The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe. J Neurol 2000; 247(11): 835– 840.
  • Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res 2001; 10: 395–404.
  • Jenkinson C, Hobart J, Chandola T et al. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol 2002; 249: 178–183.
  • Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999; 53(1): 46–50.
  • Jenkinson C, Fitzpatrick R, Brennan CM et al. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 1999; 246(Suppl 3): III16–III21.
  • Kazis LE, Anderson JJ, Meenan RF. Health status as a predictor of mortality in rheumatoid arthritis: a five-year study. J Rheumatol 1990; 17(5): 609–613.
  • Waldron D, O’Boyle CA, Kearney M et al. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 1999; 17(11): 3603–3611.
  • Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191(1–2): 103–109.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.